• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

First Cancer-Specific ACO Launches

Article

The best business model for oncology care is not yet obvious to me. But it is crystal clear that innovative new models are being hatched before our eyes: First, the oncology medical home and now, the cancer-specific accountable care organization.

As reported in OT last year, The US Oncology Network had hoped that the federal government would allow cancer-specific ACOs. That idea did not fly. But US Oncology was apparently undaunted: One of its affiliates has announced its own ACO in conjunction with a private insurer and a big health system.

Read the full story: http://hcp.lv/KPnRZs

Source: Oncology Times

Related Videos
Dr Susan Vadaparampil
Dr Ameet Patel
Margaret Krackeler, MD
Margaret Krackeler, MD
Margaret Krackeler, MD
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
Dr Eric Yang
Roy Mathew, MD, screenshot
Related Content
CT lung scans | Image Credit: Peakstock - stock.adobe.com

Serial CT Response Score Predicts OS in Patients With Advanced NSCLC Receiving ICIs

February 5th 2026
Article

A deep-learning serial CT response score outperformed conventional imaging measures in predicting OS for patients with advanced NSCLC treated with ICIs.

Read More

Square Podcast Managed Care Cast AJMC_Podcast

How Medicaid Reforms Could Deepen State Coverage Gaps

October 7th 2025
Podcast

Laxmi Patel of Savista discusses how the Budget Reconciliation Act could widen Medicaid coverage gaps and strain hospitals across states.

Listen

City St. George’s researcher Ateequllah Hayat, PhD, explains newly identified mechanisms behind lapatinib resistance in HER2-positive breast cancer.

New Molecular Drivers of HER2 Breast Cancer Resistance: A Q&A With Ateequllah Hayat, PhD

February 4th 2026
Article

Ateequllah Hayat, PhD, discusses epigenetic rewiring, biomarkers, and emerging strategies to overcome lapatinib resistance in HER2+ breast cancer.

Read More

Managed Care Cast

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

July 15th 2025
Podcast

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

Listen

Congress advances sweeping PBM transparency reforms tied to Medicare Part D as part of a broader spending package. | Image Credit: PBMs_MQ-Illustrations.jpeg

PBM Reforms Signed Into Law, Reshaping Medicare Part D Drug Pricing Transparency

February 3rd 2026
Article

A spending bill advancing PBM reforms aims to delink Medicare Part D compensation from drug rebates and improve pricing transparency.

Read More

In this Q&A, Na’am Avitzur, MD, discusses how pulmonary fibrosis impacts sexual health and why addressing quality of life matters.

Pulmonary Fibrosis and Sexual Health: A Q&A With Na’ama Avitzur, MD

February 2nd 2026
Article

A European Respiratory Journal study shows pulmonary fibrosis affects sexual function and quality of life, calling for open clinician-patient conversations.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.